original ) (raw )Structure-Based Virtual Screening and Discovery of New PPARδ/γ Dual Agonist and PPARδ and γ Agonists
Dr. Priti Talwar
PLOS ONE, 2015
View PDFchevron_right
Crystal Structure of the Peroxisome Proliferator-Activated Receptor γ (PPARγ) Ligand Binding Domain Complexed with a Novel Partial Agonist: A New Region of the Hydrophobic Pocket Could Be Exploited for Drug Design
giuseppe fracchiolla
Journal of Medicinal Chemistry, 2008
View PDFchevron_right
Virtual screening, molecular dynamics, density functional theory and quantitative structure activity relationship studies to design peroxisome proliferator-activated receptor-γ agonists as anti-diabetic drugs
Nadia Afrin
Journal of Biomolecular Structure and Dynamics, 2020
View PDFchevron_right
Discovery of a Novel Selective PPARγ Ligand with Partial Agonist Binding Properties by Integrated in Silico/in Vitro Work Flow
Brask Sonne
Journal of Chemical Information and Modeling, 2013
View PDFchevron_right
Rigid and flexible docking studies on PPAR-c agonists: key interactions for a better antihyperglycemic activity and in silico pharmacodynamic activity versus experimental in vivo activity
Prashantha Kumar BR
View PDFchevron_right
Flexible ligand recognition of peroxisome proliferator-activated receptor-γ (PPARγ)
Hiroaki Tokiwa
Bioorganic & Medicinal Chemistry Letters, 2010
View PDFchevron_right
Screening and Identification of Structural Analogs of GW9662 and T0070907 Potent Antagonists of Peroxisome Proliferator-Activated Receptor Gamma: In-Silico Drug-Designing Approach
Virupaksha Bastikar
Journal of Proteomics & Bioinformatics
View PDFchevron_right
I IN ND DO O A AM ME ER RI IC CA AN N J JO OU UR RN NA AL L O OF F P PH HA AR RM MA AC CE EU UT TI IC CA AL L S SC CI IE EN NC CE ES S IN SILICO BASED VIRTUAL SCREENING FOR BIOACTIVE PPAR-γ AGONISTS
Editor iajps
View PDFchevron_right
Flexible ligand recognition of peroxisome proliferator-activated receptor-? (PPAR?)
Hiroaki Tokiwa
Bioorg Medicinal Chem Letter, 2010
View PDFchevron_right
Ligand Based Pharmacophore Modeling and Virtual Screening for Novel Antidiabetics Targeting PPAR-gamma
Prashant Gahtori
2020
View PDFchevron_right
Structural and Dynamic Elucidation of a Non-acid PPARγ Partial Agonist: SR1988
John Bruning
Nuclear Receptor Research, 2018
View PDFchevron_right
Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode
Giorgio Pochetti
Scientific Reports, 2016
View PDFchevron_right
Structural insights for the design of new PPARgamma partial agonists with high binding affinity and low transactivation activity
Mayte Blay
Journal of Computer-Aided Molecular Design, 2011
View PDFchevron_right
Structure based Docking and Molecular dynamics studies: Peroxisome proliferator-activated receptors–α/γ dual agonists for treatment of metabolic disorders
Virendra Nath Srivastav
Journal of Biomolecular Structure and Dynamics, 2019
View PDFchevron_right
In silico structure-based drug design approach to develop novel pharmacophore model of human peroxisome proliferator-activated receptor γ agonists
Divya Yadav
Medicinal Chemistry Research, 2011
View PDFchevron_right
Design, synthesis, molecular docking, and in vitro antidiabetic activity of novel PPARγ agonist
Prof. Sunita Malhotra
Monatshefte für Chemie - Chemical Monthly, 2018
View PDFchevron_right
A Comparative Study on Selective PPAR Modulators Through Quantitative Structure-Activity Relationship, Pharmacophore and Docking Analyses
Kunal Roy
Current computer-aided drug design, 2017
View PDFchevron_right
Identification of a PPAR Delta Agonist: An In Silico Approach Towards Drug Design for Metabolic Syndrome
Asha Abraham
Prospects in Bioscience: Addressing the Issues, 2012
View PDFchevron_right
Design, Synthesis and Virtual Screening of Certain 2-PYRAZOLIN-5-ONE and PYRAZOLIDINE-3, 5- Dione Derivatives as Potential Ppar Agonists
maiy jaballah
View PDFchevron_right
Docking-based virtual screening for ligands of G protein-coupled receptors: Not only crystal structures but also in silico models
Giulio Ferino
Journal of Molecular Graphics and Modelling, 2011
View PDFchevron_right
In silico identification of a potentially novel binding modality for 1,3-dicarbonyl compounds having 2(3h)-benzazolonic heterocycles within the pparγ ligand binding pocket : a de novo design study
Dr. Claire Shoemake
2014
View PDFchevron_right
Rational design and synthesis of some PPAR-g agonists: Substituted benzylideneamino-benzylidene-thiazolidine-2,4-diones
Dr. Animeshchandra haldar
View PDFchevron_right
Discovering highly selective and diverse ppAR-delta agonists by ligand based machine learning and structural modeling
Anwar Rayan
View PDFchevron_right
Structure-based identification of novel PPAR gamma ligands
Ana Carolina Migliorini Figueira
Bioorganic & Medicinal Chemistry Letters, 2013
View PDFchevron_right
Design of Novel Compounds with the Potential of Dual PPARγ/α Modulation for the Management of Metabolic Syndrome
Dr. Claire Shoemake
Nuclear Receptor Research, 2017
View PDFchevron_right
DESIGN, IN SILICO DOCKING AND PREDICTIVE ADME PROPERTIES OF SOME THIAZOLIDINE-2, 4-DIONES DERIVATIVES AS PPARγ MODULATORS
International Journal of Pharmacy and Pharmaceutical Sciences (IJPPS)
International Journal of Pharmacy and Pharmaceutical Sciences, 2016
View PDFchevron_right
Structure-Based Virtual Screening and Discovery of New Bi-functional DAPK1 Inhibitors
Dr. Priti Talwar
Molecular Biotechnology, 2023
View PDFchevron_right
Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent
adhirai marimuthu
2009
View PDFchevron_right
Structure-Based Drug Design: Docking and Scoring
SUMAYA AHMED
View PDFchevron_right
Chemical Crosslinking Mass Spectrometry Reveals the Conformational Landscape of the Activation Helix of PPARγ; a Model for Ligand-Dependent Antagonism
John Bruning
Structure , 2018
View PDFchevron_right
Structural and Dynamical Insight into PPARγ Antagonism: In Silico Study of the Ligand-Receptor Interactions of Non-Covalent Antagonists
Filip Fratev
International Journal of Molecular Sciences, 2015
View PDFchevron_right
A Molecular Dynamics-Shared Pharmacophore Approach to Boost Early-Enrichment Virtual Screening: A Case Study on Peroxisome Proliferator-Activated Receptor α
Alessandro Padova
ChemMedChem, 2017
View PDFchevron_right
A combined ligand and structure based approach to design potent PPAR-alpha agonists
Gaurao Dhoke
Journal of Molecular Structure, 2012
View PDFchevron_right